John Spanomanolis

Garwood, NJ (USA)
Role(s):
Founder/Owner/Principal

Airivna

Location: Garwood
Industry: Bio-Technology
Year Founded: 2008
Number Employees: 1-10 people
Description: Airivna is a nanotechnological medical device company. The aim of Airivna is to use nanotechnology in order to improve the quality of life. Quality of life is improved by both precise measurements and minimally invasive procedures. Patents are currently pending for innovative cardiovascular and diabetic research. Cardiovascular research includes but not limited to improvements on implantable cardioverter defibrillators (ICD). The N-ICD provides unprecedented accuracy and additional unprecedented preventive measurements. Non invasive cardiovascular research is currently available upon request. Diabetes research involves a continual, up to the second, non invasive, reading of the glucose – insulin level. Ideal for all people, and optimal for hemophiliacs. Non invasive diabetic research is currently available upon request.